Brief: CytomX Therapeutics Names Chris Ogden As Chief Financial Officer
17/06/2024 23:36
June 17 (Reuters) - CytomX Therapeutics Inc CTMX.O :
* CYTOMX THERAPEUTICS PROMOTES CHRIS OGDEN TO CHIEF
FINANCIAL
OFFICER
Source text for Eikon: ID:nGNXc5BFMV
Further company coverage: CTMX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on CytomX Therapeutics
See all newsCytomX Q2 revenue misses, partly hurt by lower research activities in the Astellas collaboration
CytomX Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Cytomx Therapeutics Announces Appointment Of Charles Fuchs, M.D., M.P.H., To The Board Of Directors
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway